Facilitating Antibacterial Drug Development in a Time of Great Need

The continued development of new antibacterial drugs is critical to meet patient and public health needs. In this editorial, authors from the US Food and Drug Administration and European Medicines Agency reflect on the role of public–private partnerships and the development of clinical trials networ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2016-08, Vol.63 (suppl 2), p.S27-S28
Hauptverfasser: Cox, Edward, Cavaleri, Marco, Eichler, Hans-Georg, Woodcock, Janet, Borio, Luciana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The continued development of new antibacterial drugs is critical to meet patient and public health needs. In this editorial, authors from the US Food and Drug Administration and European Medicines Agency reflect on the role of public–private partnerships and the development of clinical trials networks as agents to guide and perform quality studies of antibacterial drugs.
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciw257